EUVIMEDEUVIMED entdecken
Crossref

Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation

Md Matiur Rahman Sarker, Saikat Fakir, Madan Sigdel, Keith Jackson, Nektarios Barabutis

Experimental Eye Research · 2026

DOI: 10.1016/j.exer.2026.111168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2026. Verfasst von Md Matiur Rahman Sarker und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Hauptthemen laut MEDLINE: Lipopolysaccharides, Endothelium, Corneal, Growth Hormone-Releasing Hormone, Sermorelin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Edward Via College of Osteopathic Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The corneal endothelium preserves corneal transparency by regulating water movement between the anterior chamber and the stroma. Pathological conditions may lead to progressive corneal edema due to impairment of the endothelial pump-barrier function. In this study, we investigated the effects of JV-1-36, which is a growth hormone - releasing hormone antagonist (GHRHAnt), in an in vitro model of lipopolysaccharides (LPS)-induced corneal endothelial injury. Our findings suggest that JV-1-36 alleviates the effects of LPS in endothelial corneal cells, suppresses endothelial hyperpermeability and reactive oxygen species (ROS) generation, mitigates MAPK and STAT activation, and reduces pro-inflammatory cytokine production.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesEndothelium, CornealGrowth Hormone-Releasing HormoneSermorelinKeratitisReactive Oxygen SpeciesAnimalsCytokinesCells, CulturedHumansBlotting, Western

Stichwörter der Autor:innen

EyeInflammationReactive oxygen species

Substanzen

LipopolysaccharidesReactive Oxygen SpeciesGrowth Hormone-Releasing HormoneCytokinesSermorelin

Autor:innen und Institutionen

  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
  • School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA. Electronic address: barabutis@ulm.edu.

Förderung

  • Edward Via College of Osteopathic Medicine

Zitieren

APA

Sarker, M. M. R., Fakir, S., Sigdel, M., Jackson, K., & Barabutis, N. (2026). Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation. Experimental Eye Research. https://doi.org/10.1016/j.exer.2026.111168

Vancouver

Sarker MMR, Fakir S, Sigdel M, Jackson K, Barabutis N. Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation. Experimental Eye Research. 2026. doi:10.1016/j.exer.2026.111168

BibTeX
@article{Sarker2026,
  author = {Sarker, Md Matiur Rahman and Fakir, Saikat and Sigdel, Madan and Jackson, Keith and Barabutis, Nektarios},
  title = {Growth hormone - releasing hormone antagonists protect endothelial corneal cells against lipopolysaccharides-induced inflammation},
  journal = {Experimental Eye Research},
  year = {2026},
  doi = {10.1016/j.exer.2026.111168}
}
Kostenlos starten →